Cargando…
A retrospective analysis of actionable pharmacogenetic/genomic biomarker language in FDA labels
The primary goal of precision medicine is to maximize the benefit‐risk relationships for individual patients by delivering the right drug to the right patients at the right dose. To achieve this goal, it has become increasingly important to assess gene‐drug interactions (GDIs) in clinical settings....
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301579/ https://www.ncbi.nlm.nih.gov/pubmed/33742770 http://dx.doi.org/10.1111/cts.13000 |